BAD BUGS, NO DRUGS 2002–2020: PROGRESS, CHALLENGES, AND CALL TO ACTION

door BOUCHER, HELEN W.
Gepubliceerd in Trans Am Clin Climatol Assoc (2020)

Editorial Commentary: Early High-Dose Daptomycin for Methicillin-Resistant Staphylococcus aureus Bloodstream Infections With Elevated Vancomycin Minimum Inhibitory Concentrations:...

door Weston, Adam, Boucher, Helen W.
Gepubliceerd in 2013

Dalbavancin for the treatment of acute bacterial skin and skin structure infections

door Ramdeen, Sheena, Boucher, Helen W
Gepubliceerd in Expert Opin Pharmacother (2015)

What’s Hot in Clinical Infectious Diseases? 2019 IDWeek Summary

door Moss, Sean, Boucher, Helen W
Gepubliceerd in Open Forum Infect Dis (2020)

Current Concepts in Antimicrobial Therapy Against Select Gram-Positive Organisms: Methicillin-Resistant Staphylococcus aureus, Penicillin-Resistant Pneumococci, and Vancomycin-Resi...

door Rivera, Ana Maria, Boucher, Helen W.
Gepubliceerd in 2011

In Vitro Activities of the Glycylcycline GAR-936 against Gram-Positive Bacteria

door Boucher, Helen W., Wennersten, Christine B., Eliopoulos, George M.
Gepubliceerd in 2000

In Vivo Activity of Evernimicin (SCH 27899) against Methicillin-Resistant Staphylococcus aureus in Experimental Infective Endocarditis

door Boucher, Helen W., Thauvin-Eliopoulos, Claudie, Loebenberg, David, Eliopoulos, George M.
Gepubliceerd in 2001

Design of clinical trials of antibacterial agents for community-acquired bacterial pneumonia

door Spellberg, Brad, Lewis, Roger J, Boucher, Helen W, Brass, Eric P
Gepubliceerd in 2011

Community-based outpatient parenteral antimicrobial therapy (CoPAT) for Staphylococcus aureus bacteraemia with or without infective endocarditis: analysis of the randomized trial c...

door Rehm, Susan, Campion, Marilyn, Katz, David E., Russo, Rene, Boucher, Helen W.
Gepubliceerd in 2009

Coronavirus disease 2019 (COVID-19) vaccinations and preservation of the healthcare workforce

door Andujar Vazquez, Gabriela M., Morely, Jonathan, Boucher, Helen W., Doron, Shira I.
Gepubliceerd in Infect Control Hosp Epidemiol (2021)

Safety of Dalbavancin in the Treatment of Skin and Skin Structure Infections: A Pooled Analysis of Randomized, Comparative Studies

door Dunne, Michael W., Talbot, George H., Boucher, Helen W., Wilcox, Mark, Puttagunta, Sailaja
Gepubliceerd in Drug Saf (2015)

Bacterial antibiotic resistance development and mutagenesis following exposure to subinhibitory concentrations of fluoroquinolones in vitro: a systematic review of the literature

door Ching, Carly, Orubu, Ebiowei S F, Sutradhar, Indorica, Wirtz, Veronika J, Boucher, Helen W, Zaman, Muhammad H
Gepubliceerd in JAC Antimicrob Resist (2020)

Drug Use and Postoperative Mortality Following Valve Surgery for Infective Endocarditis: A Systematic Review and Meta-analysis

door Hall, Ryan, Shaughnessy, Michael, Boll, Griffin, Warner, Kenneth, Boucher, Helen W, Bannuru, Raveendhara R, Wurcel, Alysse G
Gepubliceerd in Clin Infect Dis (2019)

Antimicrobial Agents for Complicated Skin and Skin-Structure Infections: Justification of Noninferiority Margins in the Absence of Placebo-Controlled Trials

door Spellberg, Brad, Talbot, George H., Boucher, Helen W., Bradley, John S., Gilbert, David, Scheld, W. Michael, Edwards, John, Bartlett, John G.
Gepubliceerd in 2009

Considerations for Clinical Trials of Staphylococcus aureus Bloodstream Infection in Adults

door Holland, Thomas L, Chambers, Henry F, Boucher, Helen W, Corey, G Ralph, Coleman, Rebecca, Castaneda-Ruiz, Bibiana, Fowler, Vance G
Gepubliceerd in Clin Infect Dis (2019)

10 × '20 Progress—Development of New Drugs Active Against Gram-Negative Bacilli: An Update From the Infectious Diseases Society of America

door Boucher, Helen W., Talbot, George H., Benjamin, Daniel K., Bradley, John, Guidos, Robert J., Jones, Ronald N., Murray, Barbara E., Bonomo, Robert A., Gilbert, David
Gepubliceerd in 2013

White Paper: Developing Antimicrobial Drugs for Resistant Pathogens, Narrow-Spectrum Indications, and Unmet Needs

door Boucher, Helen W, Ambrose, Paul G, Chambers, H F, Ebright, Richard H, Jezek, Amanda, Murray, Barbara E, Newland, Jason G, Ostrowsky, Belinda, Rex, John H
Gepubliceerd in J Infect Dis (2017)

Comparison of Treatment Outcomes between Analysis Populations in the RESTORE-IMI 1 Phase 3 Trial of Imipenem-Cilastatin-Relebactam versus Colistin plus Imipenem-Cilastatin in Patie...

door Kaye, Keith S., Boucher, Helen W., Brown, Michelle L., Aggrey, Angela, Khan, Ireen, Joeng, Hee-Koung, Tipping, Robert W., Du, Jiejun, Young, Katherine, Butterton, Joan R., Paschke, Amanda
Gepubliceerd in Antimicrob Agents Chemother (2020)

1339. Results for the Supplemental Microbiological Modified Intent-to-Treat (SmMITT) Population of the RESTORE-IMI 1 Trial of Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/...

door Kaye, Keith, File, Thomas, Boucher, Helen W, Brown, Michelle, Aggrey, Angela, Khan, Ireen, Joeng, Hee-Koung, Tipping, Robert, Du, Jiejun, Young, Katherine, Butterton, Joan, Kartsonis, Nicholas A, Paschke, Amanda
Gepubliceerd in Open Forum Infect Dis (2018)

1951. Nephrotoxicity Associated With Imipenem/Cilastatin/Relebactam (IMI/REL) vs. Imipenem/Cilastatin Plus Colistin (IMI+CST) in Patients With Imipenem-Nonsusceptible (NS) Bacteria...

door Brown, Michelle, Motsch, Johann, Kaye, Keith, File, Thomas, Boucher, Helen W, Vendetti, Neika, Aggrey, Angela, Joeng, Hee-Koung, Tipping, Robert, Du, Jiejun, Depestel, Daryl D, Butterton, Joan, Kartsonis, Nicholas A, Paschke, Amanda
Gepubliceerd in Open Forum Infect Dis (2018)